IMPURITIES AVAILABLE FOR 'Preladenant'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Preladenant. Preladenant is a selective adenosine A₂A receptor antagonist developed for the treatment of Parkinson’s disease as an adjunct to levodopa therapy. By blocking A₂A receptors in the basal ganglia, it helps restore dopaminergic signaling and improve motor control without directly stimulating dopamine receptors. Preladenant was designed to reduce motor fluctuations and “off” periods in Parkinson’s patients. It is administered orally, shows good central nervous system penetration, and is metabolized primarily in the liver (CYP1A2). Although it demonstrated promising early clinical results, later phase III trials failed to show significant efficacy compared to placebo. Common side effects reported include insomnia, nausea, and headache. Despite limited clinical use, preladenant remains a research compound of interest for neuroprotective and dopaminergic modulation studies. Buy high quality Preladenant from Omsynth Lifesciences.